|
|
Article: Composition Patent To Treat Viral Infections Issued And Assigned To Advanced Viral Research Corp.
- Article from:
- Business Wire
- Article date:
- October 18, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Medical Writers
YONKERS, N.Y.--(BUSINESS WIRE)--Oct. 18, 2001
Advanced Viral Research Corp.(OTCBB:ADVR) today announced the award of U.S. Patent NO. 6303153 entitled "Preparation of a Therapeutic Composition."
This issued patent protects the preparation and composition of Product R, the non-toxic peptide-nucleic acid immunomodulator developed by Advanced Viral Research Corp.
Advanced Viral Research Corp. is pleased that its shareholders interests have been protected by the grant of this patent. Patents provide shielding for the Company's intellectual property and also facilitate introduction to potential marketing ...